Patients should maintain close contact with their health-care provider during
treatment with MDT, and periodic follow-up visits are recommended.
- The WHO recommends the monthly direct supervision by a health-care provider
during the administration of rifampicin.
- Periodic blood testing during treatment is recommended, as well as yearly
skin scrapings when possible.
- The relapse rate after the administration of MDT is about 1%. Therefore,
patients should still be followed by a health-care provider for five to 10 years after
completion of MDT.
- Some patients with leprosy may require psychological counseling, physical
therapy, and occupational therapy.
Must Read Articles Related to Leprosy
A corneal ulcer is an open sore on the cornea, the thin clear structure overlying the iris, which is the colored part of your eye.learn more >>
Eye pain has many causes, signs, symptoms, and treatments. It's also described as pain behind the eye, eye socket pain, or shooting pain in the eye. Headaches a...learn more >>
Fever in Adults
A fever is a body temperature of 100.4 F or greater. A fever may be caused by a virus, bacteria, fungus, blood clot, tumor, drug, or the environment. Treatment ...learn more >>